4.7 Article

Differential susceptibility of Dectin-1 isoforms to functional inactivation by neutrophil and fungal proteases

Journal

FASEB JOURNAL
Volume 32, Issue 6, Pages 3385-3397

Publisher

WILEY
DOI: 10.1096/fj.201701145R

Keywords

elastase; C-type lectin-like receptor; cystic fibrosis; Aspergillus

Funding

  1. U.S. National Institutes of Health (NIH)
  2. National Institute of General Medical Sciences [GM62116]
  3. Sir Henry Dale Fellowship - Wellcome Trust
  4. Royal Society [099953/Z/12/Z]
  5. National Institute for Social Care and Health Research Academic Health Science collaboration (Wales, United Kingdom)
  6. Wellcome Trust Investigator Award [WT107964MA]
  7. Complement UK
  8. Alexion Pharmaceuticals
  9. MRC [G0601617, UKDRI-3001] Funding Source: UKRI

Ask authors/readers for more resources

Patients with cystic fibrosis (CF) experience chronic or recurrent bacterial and fungal lung infections. Many patients with CF cannot effectively clear Aspergillus from their lungs. This may result in IgE sensitization and the development of allergic bronchopulmonary aspergillosis, or invasive infections, such as Aspergillus bronchitis. Lung disease in patients with CF is associated with neutrophil-dominated inflammation and elevated levels of the serine protease, neutrophil elastase (NE). Various C-type lectin-like receptors (CLRs), including Dectin-1 and Dectin-2, are involved in the immune response to Aspergillus. Here, we show that purified NE cleaves Dectin-1 in an isoform-specific manner. Bronchoalveolar lavage fluid from patients with CF, which contains high NE activity, induces Dectin-1 cleavage. Similarly, filtrate from a protease-producing strain of Aspergillus fumigatus induces isoform-specific cleavage of Dectin-1. Dectin-1 knockout (KO) cells and NE-treated cells demonstrated reduced phagocytosis of zymosan, a fungal cell wall preparation. In addition, NE cleaves 2 other CLRs, Dectin-2 and Mincle, and fungal-induced cytokine production was reduced in Dectin-1 KO cells, Dectin-2 KO cells, and NE-treated cells. Thus, Dectin-1 and Dectin-2 cleavage by NE and/or A. fumigatus-derived proteases results in an aberrant antifungal immune response that likely contributes to disease pathology in patients with CF.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Respiratory System

Pathogen detection. The bread and butter

Julian T. Forton

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Respiratory System

The lung microbiota in children with cystic fibrosis captured by induced sputum sampling

Rebecca Weiser, Juliette Oakley, Katherine Ronchetti, Jo-Dee Tame, Sven Hoehn, Tomasz P. Jurkowski, Eshwar Mahenthiralingam, Julian T. Forton

Summary: Spatial heterogeneity of the lower airway microbiota was observed in children with cystic fibrosis (CF). Induced sputum (IS) sampling was found to capture a representative microbiota signature of the lower airway in CF children.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Veterinary Sciences

3R Blackboard: A platform for animal and organ sharing

Magdalena A. Czubala, Eva Eilles, Andreas Staubi, Natacha Ipseiz, Michael Vogt, Leonie Zieglowski, Lisa Ernst, Rene H. Tolba, Philip R. Taylor, Ralf Weiskirchen

Summary: The research team has proposed a digital platform called '3R Blackboard' to facilitate the sharing of surplus biological materials from animals, aiming to reduce the number of animals used. Pilot study has shown that this platform is highly effective, resulting in a significant reduction in the number of animals used, as well as resource saving, knowledge exchange, and establishment of new collaborations.

LABORATORY ANIMALS (2022)

Article Medicine, General & Internal

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby, Guilherme Pessoa-Amorim, Natalie Staplin, Jonathan R. Emberson, Mark Campbell, Enti Spata, Leon Peto, Nigel J. Brunskill, Simon Tiberi, Victor Chew, Thomas Brown, Hasan Tahir, Beate Ebert, David Chadwick, Tony Whitehouse, Rahuldeb Sarkar, Clive Graham, J. Kenneth Baillie, Buddha Basnyat, Maya H. Buch, Lucy C. Chappell, Jeremy Day, Saul N. Faust, Raph L. Hamers, Thomas Jaki, Edmund Juszczak, Katie Jeffery, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J. Landray

Summary: In patients hospitalized with COVID-19, aspirin was not associated with reductions in 28-day mortality or in the risk of progressing to invasive mechanical ventilation or death, but was associated with a small increase in the rate of being discharged alive within 28 days.

LANCET (2022)

Article Biochemistry & Molecular Biology

The Candida albicans toxin candidalysin mediates distinct epithelial inflammatory responses through p38 and EGFR-ERK pathways

Spyridoula-Angeliki Nikou, Chunsheng Zhou, James S. Griffiths, Natalia K. Kotowicz, Bianca M. Coleman, Mary J. Green, David L. Moyes, Sarah L. Gaffen, Julian R. Naglik, Peter J. Parker

Summary: The fungal pathogen Candida albicans secretes the peptide toxin candidalysin, which activates MAPK p38 and ERK pathways, leading to inflammatory response and immune activation. p38 pathway mainly promotes IL-6 release, Src pathway promotes EGFR phosphorylation, and ERK pathway promotes c-Fos activation and chemokine release.

SCIENCE SIGNALING (2022)

Article Medicine, General & Internal

Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation

Tapio Paljarvi, Julian Forton, Sierra Luciano, Kimmo Herttua, Seena Fazel

Summary: This study found that patients with asthma or allergic rhinitis had increased odds of adverse neuropsychiatric outcomes after montelukast initiation.

JAMA NETWORK OPEN (2022)

Article Neurosciences

Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models

Sarah M. Carpanini, Megan Torvell, Ryan J. Bevan, Robert A. J. Byrne, Nikoleta Daskoulidou, Takashi Saito, Takaomi C. Saido, Philip R. Taylor, Timothy R. Hughes, Wioleta M. Zelek, B. Paul Morgan

Summary: Complement plays a role in synaptic pruning and synaptic loss in Alzheimer's disease, and the lytic membrane attack complex (MAC) is involved in this process. Experimental evidence shows that C1q, C3 fragments and MAC are increased in Alzheimer's disease mice, and inhibition of MAC formation can reduce synaptic loss.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Review Microbiology

The Use of Host Biomarkers for the Management of Invasive Fungal Disease

James S. Griffiths, Selinda J. Orr, Charles Oliver Morton, Juergen Loeffler, P. Lewis White

Summary: Invasive fungal disease (IFD) causes severe morbidity and mortality, and the number of IFD cases is increasing. Current IFD diagnosis relies on fungal biomarkers and clinical risk/presentation, but the diverse fungal species and diagnostic challenges lead to empirical anti-fungal treatment for high-risk patients. Recent studies have focused on host-derived biomarkers that can predict and identify IFD, enhancing diagnostic results. Once validated in larger studies, these biomarkers may optimize the clinical management of populations at risk of IFD.

JOURNAL OF FUNGI (2022)

Article Respiratory System

BTS Clinical Statement on the prevention and management of community-acquired pneumonia in people with learning disability

Julian Legg, Jamie-Leigh Allen, Morag Andrew, Charlotte Annesley, Michelle Chatwin, Hannah Crawford, Joanna Elverson, Julian Forton, Kate Oulton, Kate Renton, Alison Tavare, Hilary Tedd, A. John Simpson

THORAX (2023)

Article Respiratory System

BTS clinical statement on aspiration pneumonia

A. John Simpson, Jamie-Leigh Allen, Michelle Chatwin, Hannah Crawford, Joanna Elverson, Victoria Ewan, Julian Forton, Ronan McMullan, John Plevris, Kate Renton, Hilary Tedd, Rhys Thomas, Julian Legg

THORAX (2023)

Article Multidisciplinary Sciences

Future therapies for cystic fibrosis

Lucy Allen, Lorna Allen, Siobhan B. Carr, Gwyneth Davies, Damian Downey, Marie Egan, Julian T. Forton, Robert Gray, Charles Haworth, Alexander Horsley, Alan R. Smyth, Kevin W. Southern, Jane C. Davies

Summary: With the introduction of small molecule, mutation-specific drugs, people with cystic fibrosis are undergoing transformative change as these drugs can restore function of the defective protein CFTR. However, not all genetic variants are suitable for mutation-specific drugs and these drugs also do not correct all the clinical manifestations of the disease. More research is needed to improve treatments for cystic fibrosis.

NATURE COMMUNICATIONS (2023)

Article Cell Biology

Toll-like receptor 4 and CD11b expressed on microglia coordinate eradication of Candida albicans cerebral mycosis

Yifan Wu, Shuqi Du, Lynn H. Bimler, Kelsey E. Mauk, Lea Lortal, Nessim Kichik, James S. Griffiths, Radim Osicka, Lizhen Song, Katherine Polsky, Lydia Kasper, Peter Sebo, Jill Weatherhead, J. Morgan Knight, Farrah Kheradmand, Hui Zheng, Jonathan P. Richardson, Bernhard Hube, Julian R. Naglik, David B. Corry

Summary: The fungal pathogen Candida albicans can enter the mouse brain from the blood and trigger two neuroimmune sensing mechanisms involving secreted as-partic proteinases (Saps) and candidalysin. The Saps disrupt the blood-brain barrier and promote fungal invasion, while candidalysin engages with microglia to defend against the fungus. These findings suggest that clearance of Candida albicans from the brain is achieved through innate immune mechanisms involving Saps, AD, candidalysin, and CD11b.

CELL REPORTS (2023)

Article Endocrinology & Metabolism

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby, Natalie Staplin, Leon Peto, Jonathan R. Emberson, Mark Campbell, Guilherme Pessoa-Amorim, Buddha Basnyat, Louise Thwaites, Rogier van Doorn, Raph L. Hamers, Jeremy Nel, John Amuasi, Manisha Rawal, Dipansu Ghosh, Jonathan Douse, Fergus Hamilton, Anthony Kerry, Pinky Thu-Ta, John Widdrington, Christopher A. Green, Purav Desai, Richard Stewart, Nguyen Thanh Phong, J. Kenneth Baillie, Maya Buch, Saul N. Faust, Thomas Jaki, Edmund Juszczak, Katie Jeffery, Marian Knight, Wei Shen Lim, Alan Montgomery, Aparna Mukherjee, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J. Landray

Summary: Empagliflozin is not associated with reduced mortality, hospital stay, or progression to invasive mechanical ventilation or death in hospitalized adults with COVID-19.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Article Medicine, General & Internal

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Peter W. Horby, Jonathan R. Emberson, Marion Mafham, Mark Campbell, Leon Peto, Guilhenne Pessoa-Amorim, Enti Spata, Natalie Staplin, Catherine Lowe, David R. Chadwick, Christopher Brightling, Richard Stewart, Paul Collini, Abdul Ashish, Christopher A. Green, Ben Prudon, Timothy Felton, Anthony Kerry, J. Kenneth Baillie, Maya H. Such, Jeremy Day, Saul N. Faust, Thomas Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Richard Haynes, Martin J. Landray

Summary: This study evaluated the use of baricitinib in the treatment of patients hospitalized with COVID-19. The results showed that baricitinib significantly reduced the risk of death, although the effect size was slightly smaller than previous trials. Overall evidence suggests that JAK inhibitors can reduce mortality in hospitalized COVID-19 patients by about 20%.

LANCET (2022)

No Data Available